ExploreWatchlistsPricing
  1. JP-listed companies
  2. KAKEN PHARMACEUTIAL CO., LTD.
  3. Financials
  4. Return on equity (%)

KAKEN PHARMACEUTIAL CO., LTD. (4521)

Market cap
¥191.8B
P/E ratio
68.7x
A Japanese pharmaceutical company that manufactures and sells medicines, medical devices, and agricultural chemicals while also operating real estate leasing.
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndReturn on equity (%) (Million JPY)YoY (%)
Mar 31, 20259.4+64.51%
Mar 31, 20245.7+44.81%
Mar 31, 20234-43.25%
Mar 31, 20227-31.29%
Mar 31, 202110.1-34.73%
Mar 31, 202015.5+2.58%
Mar 31, 201915.1-13.99%
Mar 31, 201817.6-23.09%
Mar 31, 201722.9-9.68%
Mar 31, 201625.3+51.62%
Mar 31, 201516.7

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat